3-(3,4-Dihydroisoquinolin-2(1H)-yl)propan-1-amine, 98%, 250mg

(S)-3-AMINO-4,4,4-TRIFLUOROBUTANOIC ACID, 95.0%, 1g

1-bromo-dibenzofuran-4-ol, 97%, 250mg

5-[3,4-(Ethylenedioxy)phenyl]-5-oxovaleric acid, 95.0%, 25g

(2-Chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)(morpholino)methanone, 95.0%, 25g

1,3-Bis(trifluoromethyl)benzene, 99.00%, 250g

2,5-Dioxopyrrolidin-1-yl 3-(3-methyl-3H-diazirin-3-yl)propanoate, 97%, 100mg

N-o-Tolylformamide, 95.0%, 100g

3,3'-Diiodo-L-thyronine, 95.0%, 5g

�-Bromostyrene, 97.00%, 10g

1-Methyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole, 95.0%, 1g

Quinoline>97.0%(GC)25g

Needles KF for GASTIGHT® syringes series 1000 Point type 3, 6 pieces